100 results about "Vitamin L2" patented technology

The invention discloses a vitamin K2 composite micro-capsule system with stomach protection and intestine slow release functions and a preparation method and application thereof, the vitamin K2 composite micro-capsule system with stomach protection and intestine slow release functions comprises three layers, namely a core layer, a middle layer and an outer layer from inside to outside in sequence; the core layer is formed by coating vitamin K2 with a zein-lac hydrophobic core, the middle layer is a pea protein-pectin electrostatic compound, and the outer layer is sodium alginate and chitosan double-network gel. The micro-capsule system provided by the invention can be tightly combined in a gastric acid environment after being orally taken, the release of active ingredients in the stomach is reduced, and then the micro-capsule system stays at intestinal mucosa for a long time and slowly releases contents, so that the functions of the micro-capsule system are slowly presented outside, the half-life period is prolonged, and the action effect is improved. Vitamin K2 directly or indirectly participates in and regulates various physiological processes related to health, and plays an important role in the aspects of maintaining bone health, preventing cardiovascular diseases, protecting nerves, improving metabolism and the like.

This invention discloses an acne-repairing and repairing composition for promoting microcirculation in acne-prone and sensitive skin, and its application, relating to the field of cosmetic technology. The invention provides an acne-repairing and repairing composition comprising the following components in parts by weight: Vitamin K2 0.05-1 parts, Swertia japonica extract 0.1-1.5 parts, Guaiac extract 0.1-2 parts, Cerium oxide microspheres 0.005-0.1 parts, and Morus alba root extract 0.5-5 parts; wherein the average particle size of the Cerium oxide microspheres is 0.2-3 μm, and the Cerium oxide microspheres contain Ce. 3+ The Ce 3+ The molar percentage of cerium oxide microspheres is 30-38%. This invention provides an acne-repairing composition. In actual experiments, the inventors discovered that when vitamin K2, Swertia trifasciata extract, Guaiac extract, cerium oxide microspheres, and mulberry root extract are present simultaneously, the five components can synergistically work together to reduce skin roughness and improve rosacea and acne.

The invention discloses application of vitamin K2 in preparation of an anti-hair loss composition. Research finds that the vitamin K2 has the effects of promoting VEGF gene expression and inhibiting IL-6 and DKK-1 gene expression in an androgen type alopecia model, and has the effects of promoting Gas6, VEGF and TGF gene expression in a pressure type alopecia model, so that a good alopecia prevention and treatment effect is achieved, and toxic and side effects are few.

The present disclosure relates to the synthesis of Vitamin K2 bearing varying prenyl side chains. The synthesis comprises the reaction of phenyl sulfone of tert-butyl dimethyl silyl (TBDMS) protected mono prenyl menadiol with prenyl halides bearing varying prenyl units in the presence of the phase transfer catalyst followed by reductive desulphonation to yield TBDMS ether of Vitamin K2. The TBDMS ether is then oxidized in the presence of chromium trioxide and periodic acid to yield the corresponding Vitamin K2.

The invention relates to the field of detection, in particular to a method for simultaneously detecting multiple fat-soluble vitamins, which comprises the following steps: (S.1) carrying out protein precipitation and liquid-liquid extraction on a sample to be detected to obtain an extract containing fat-soluble vitamins; (S.2) carrying out derivatization reaction on the extract by using a PTAD derivatization reagent; and (S.3) analyzing the derivatized product by adopting a liquid chromatography-tandem mass spectrometry method, wherein the detected target fat-soluble vitamins comprise vitamin A, vitamin E, 25-hydroxy vitamin D2, 25-hydroxy vitamin D3, vitamin K1, vitamin K2 and vitamin K2. According to the application, PTAD is creatively adopted as a unified derivatization reagent, simultaneous and efficient derivatization of seven fat-soluble vitamins is successfully realized, the detection sensitivity of low-content targets, especially vitamin D, K2 and the like, is greatly improved, and the core problems of weak signal response and difficulty in accurate quantification are solved.

The present invention provides a vitamin premix and a preparation process thereof, and belongs to the technical field of food additives, the preparation process is as follows: fat-soluble vitamin mixed particles, mixed water-soluble vitamins and mixed minerals are added into a mixer for mixing, then vitamin C, magnesium taurate, amino acids and tricalcium phosphate are added for continuous mixing, and sieving is performed to obtain the vitamin premix. Wherein the fat-soluble vitamin mixed particles comprise the following raw materials: vitamin A, vitamin E acetate, vitamin D3, vitamin K2, Arabic gum, modified protein and beta-cyclodextrin; the mixed water-soluble vitamins comprise the following raw materials: vitamin B1, vitamin B2, vitamin B5, vitamin B12, folic acid and nicotinamide; the mixed mineral substance comprises the following raw materials: ferrous glycinate, calcium citrate, magnesium citrate and zinc glycinate. The vitamin premix prepared by the invention can be used as a nutritional supplement in various foods, is convenient to use, and has good stability and mixing uniformity.

This invention belongs to the field of biotechnology and discloses a recombinant strain of Saccharomyces cerevisiae that enhances the efficient synthesis of vitamin K2 and its application. By heterologously integrating the hepS / T and naphthoquinone cyclotransferase genes (menA) of Bacillus subtilis, four genetically engineered strains were constructed based on the designed MK-7 biosynthetic pathway: YK-1, YK-2, YK-3, and YK-4. YK-1 is an expression strain containing the target genes MenF, MenD, and MenH; YK-2 is an expression strain integrating the target genes MenC, MenE, and MenB on the basis of YK-1; YK-3 is an expression strain integrating the target genes hepS and hepT on the basis of YK-2; and YK-4 is an expression strain integrating the target genes yuxO, MenA, and MenG on the basis of YK-3. YK-4 is the final engineered strain that produces high levels of vitamin K2. The optimal fermentation time was determined by measuring OD600 and yield curves. YK-4 reached its maximum cell concentration in 18 hours, which can effectively shorten the fermentation cycle.

The invention provides a pharmaceutical composition for improving bone mineral density and a preparation method thereof, and belongs to the technical field of biological medicine, the pharmaceutical composition comprises lactarius vomica extract peptide, winged yam rhizome peel extract, rainbow trout extract, calcium citrate-glycine chelate, vitamin K2 and vitamin D3. The lactarius volemus extract peptide is obtained by sequentially carrying out enzymolysis on lactarius volemus by bromelain and subtilisin and purifying and extracting enzymatic hydrolysate through an LH-60 sephadex column. The winged yam rhizome peel extract is obtained by extracting the peels of winged yam rhizome tubers with an ethanol water solution and purifying and extracting the extracting solution with an AB-8 macroporous adsorption resin column. The rainbow trout extract is a product below 5kDa obtained by sequentially performing enzymolysis on fish heads, fish skins and fish scales of rainbow trout through trypsin and lumbrukinase. All the components are compounded according to a specific proportion, and the core effect of improving the bone mineral density is achieved through two-way regulation and control of bone metabolism, optimization of calcium utilization and improvement of safety.

The present application discloses compositions comprising nanoparticles of vitamin K2, and their methods of use.

The invention provides application of a composition containing butyric acid producing bacteria and vitamin K2 in preparation of a medicine for treating osteoporosis, and relates to the technical field of biological medicines, the composition comprises butyric acid producing bacteria and vitamin K2; wherein the butyric acid producing bacteria are selected from any one or more of clostridium butyricum, rosella and clostridium praeparatum; and the vitamin K2 is selected from any one or more of menadione-4 or menadione-7. The composition can play a synergistic effect through an intestine-bone axis, and compared with a single component, the composition can more remarkably improve the bone mineral density. The composition has comprehensive effects and high safety, provides a brand-new nutrition intervention strategy with a synergistic effect for prevention and treatment of osteoporosis, and provides a brand-new possibility for preparation of medicines related to osteoporosis.

The invention belongs to the technical field of medicinal preparation processing, and particularly relates to oral liquid for supplementing calcium, vitamin D and vitamin K and a preparation method of the oral liquid. The fruit and vegetable powder is prepared from the following raw materials in parts by weight: 100 to 500 parts of calcium citrate, 0.2 to 2.5 parts of vitamin D3 emulsion, 0.4 to 5.5 parts of vitamin K2, 0 to 100 parts of casein phosphopeptides, 0.1 to 200 parts of fruit and vegetable powder, 0 to 5 parts of citric acid, 0 to 5 parts of malic acid, 0.1 to 400 parts of a sweetening agent, 0.01 to 10 parts of a thickening agent, 0.1 to 5 parts of an emulsifying agent, 0 to 2 parts of stevioside and 665 to 1395 parts of water. According to the invention, the vitamin D3 emulsion process is improved, the proper antioxidant is added, and the proper consistency is adjusted, so that the stability of the vitamin D3 in the oral liquid product is ensured, and the dosage form application range of the calcium supplement is enlarged.

The invention relates to the technical field of in-vitro detection, in particular to a sample pretreatment method and a method for detecting VK2 and VD in serum. According to the specific technical scheme, the method comprises the following steps: carrying out protein precipitation after carrying out enzymolysis on serum, taking supernate, mixing the supernate with activated magnetic beads, enabling the magnetic beads to adsorb a target object, finally eluting the magnetic beads adsorbed with the target object by using eluent, collecting the eluent, and detecting the eluent to obtain vitamin K2 (VK2) and 25-hydroxy vitamin D (VD) at the same time. The problems that pretreatment operation is tedious, health is harmed and flux is low are solved by adopting an automatic magnetic bead method; the problems that detection equipment is expensive and difficult to popularize are solved by adapting to a conventional mass spectrum platform; the technical path is not only suitable for detection of vitamin K2 and 25-hydroxyvitamin D, but also provides a solution normal form with popularization value for detection of trace micromolecular markers which are difficult to popularize due to complex pretreatment or high equipment threshold.

The present application relates to the technical field of nutritional supplement food, more specifically, to a double-protein balanced type of old-age nutritional supplement food and a preparation method thereof. The food comprises calcium, magnesium, zinc, iron, vitamin C, vitamin B6, vitamin E, vitamin B2, sodium selenite, nicotinamide, vitamin D3, vitamin A, vitamin B12, folic acid, vitamin B1 and vitamin K2. The present application is targeted at physiological characteristics and metabolic rules of middle-aged and old people, and scientifically proportioned various vitamins, minerals, essential fatty acids and antioxidant substances required by human body, so as to fully meet daily nutritional requirements of the middle-aged and old people and make up for insufficient dietary intake caused by decreased digestive and absorptive functions.

The invention relates to fermented milk containing human milk oligosaccharide 2-FL and having a bone mineral density improving function. The invention provides application of human milk oligosaccharide 2-FL in preparation of a composition for improving bone health, and further provides a composition which contains the human milk oligosaccharide 2-FL and has a function of improving bone health. The composition comprises human milk oligosaccharide 2-FL and a leavening agent, wherein the leavening agent is one or a mixture of more of streptococcus thermophilus, lactobacillus bulgaricus and a vitamin K2-producing leavening agent. Compared with other technical schemes of the same type for enhancing the bone mineral density, the calcium intake of a subject is not additionally increased, the risk that the subject suffers from organ calculi is reduced, the application range is wider, and the preparation method is suitable for being applied to various fermented milk products.

The present application discloses compositions comprising nanoparticles of vitamin K2, and their methods of use.

The invention relates to the field of bone tissue engineering and regenerative medicine, in particular to non-denatured bone protein calcium superfine powder with bone tissue oriented growth and rapid repair effects and a preparation method and application of the non-denatured bone protein calcium superfine powder, and the non-denatured bone protein calcium superfine powder comprises the following components in percentage by weight: 25%-45% of non-denatured type I collagen, 0.005%-0.05% of bone morphogenetic protein-2, 0.001%-0.02% of transforming growth factor-beta1, 0.01%-0.02% of calcium sulfate, 0.01%-0.02% of calcium sulfate, 0.01%-0.02% of calcium The bone tissue repairing agent is prepared from, by weight, 0.001%-0.02% of basic fibroblast growth factors, 20%-40% of ultramicro hydroxyapatite nanoparticles, 5%-15% of chitosan oligosaccharide, 3%-10% of mannitol calcium complex, 2%-8% of sodium hyaluronate, 0.01%-0.1% of vitamin D3, 0.01%-0.1% of vitamin K2, 5%-15% of chondroitin sulfate, 1%-4% of casein phosphopeptides and the balance auxiliary materials, and directional growth and rapid repairing of bone tissue are promoted.

The invention is suitable for the technical field of high-calcium feeds, and provides a cattle ear high-calcium feed and a preparation method thereof, the cattle ear high-calcium feed comprises the following raw materials: cattle ear leaf dry powder, corn flour, soybean meal, fish meal, bran, yeast powder, a probiotic mixture, vitamin K2, a trace element premix and salt; wherein the probiotic mixture is composed of lactic acid bacteria and lactobacillus acidophilus. The ox ear leaves are used as a main calcium source, and the content of active calcium is high; and vitamin D and vitamin K2 auxiliary factors are added, so that the bioavailability of calcium is improved.

This invention discloses a desmethylmenoprenone methyltransferase mutant, its construction method, and its applications, belonging to the field of biotechnology. Desmethylmenoprenone methyltransferase is a key enzyme in the MK-7 biosynthetic pathway, responsible for catalyzing the methylation reaction of desmethylmenoprenone to generate a series of methylnaphthoquinone (MK) products, ultimately forming MK-7. This invention, through metabolic network regulation and rational design, successfully obtained 19 single-point mutants, among which 5 mutants showed significantly higher catalytic efficiency than the wild-type enzyme. Experimental results show that the recombinant engineered bacteria constructed based on these mutants exhibit significant advantages in the whole-cell catalytic production of vitamin K2 (MK-7), with MK-7 yield increased by more than 20% compared to the wild-type strain. The excellent catalytic performance of the menG mutant provided by this invention provides strong technical support for the industrial production of vitamin K2, and has broad application prospects and market value.

Composition comprising a mineral combination: calcium, magnesium, zinc; an amino acid combination: L-lysine, L-tryptophan or other amino acids; a vitamin combination: vitamin D3, vitamin K2, vitamin A; a bioactive peptide combination: casein phosphopeptide, collagen tripeptides, egg yolk tripeptides / hydrolyzed egg yolk flour.

To provide a mitochondrial DNA nucleoid aggregation inhibitor.SOLUTION: The present invention relates to a mitochondrial DNA nucleoid aggregation inhibitor containing vitamin K1 and / or vitamin K2. The present invention also relates to a pharmaceutical composition for preventing and / or treating cardiotoxicity induced by use of an anthracycline anticancer agent, the pharmaceutical composition containing the nucleoid aggregation inhibitor, and also relates to a food composition for prevention and / or alleviation of side effects derived from an anthracycline anticancer agent, the food composition containing vitamin K1 and / or vitamin K2 as an active ingredient.SELECTED DRAWING: None

The invention relates to the technical field of functional dairy products, in particular to formula goat milk powder for middle-aged and elderly people with omega-3 and phosphatidylserine stable in intestinal tracts. Comprising the following raw materials in parts by weight: 500 to 550 parts of raw goat milk, 25 to 30 parts of an Omega 3 composite raw material, 8 to 12 parts of hydroxy calcium phosphate, 0.005 to 0.01 part of vitamin K2, 15 to 20 parts of a prebiotic composition, 350 to 400 parts of a probiotic composition, 5 to 8 parts of phosphatidylserine, 40 to 50 parts of isomaltooligosacharide, 25 to 30 parts of fructo-oligosaccharide, 30 to 50 parts of WPC34 whey protein powder, 20 to 25 parts of lecithin, 20 to 25 parts of lactobacillus casei freeze-dried bacterial powder and 0.02 to 0.03 part of vitamin E, 1-2 parts of sodium citrate; the Omega 3 composite raw material is prepared from 15 to 18 parts of linseed oil and 10 to 12 parts of algae oil; according to the intestinal steady-state omega-3 and phosphatidylserine formula goat milk powder for the middle-aged and elderly people, a multi-point synergistic protection system is constructed by compounding the omega-3 composite raw material, the hydroxyl calcium phosphate and the vitamin K2, and the problem that an existing formula is single in function is fundamentally solved.

The invention belongs to the technical field of inhalation preparations and pulmonary drug delivery, and particularly relates to an atomization preparation for vitamin K inhalation drug delivery and preparation and application thereof. According to the preparation, dipalmitoyl phosphatidylcholine, cholesterol and optional anionic phospholipid are adopted to construct a bionic lung surface activity liposome skeleton LA1, an MK-7 organic phase is intercalated into a liposome double-layer hydrophobic area under the condition of controlling temperature and an energy path, and a continuous phase containing sodium chloride, propylene glycol and a pH regulator is matched to form an isotonic near-neutral environment; a neutral oil phase, a fat-soluble antioxidant, an optional metal chelating agent and a viscosity modifier can be introduced to synergistically optimize the atomization performance. The apparent viscosity of the prepared atomization preparation at 25 DEG C is 1.0-2.5 mPa.s, the osmotic pressure is 280-320 mOsm / kg, the average particle size of lipidosome Z is 80-150 nm, the PDI is not larger than 0.25, the mass median diameter of fog drops atomized by a vibration net type atomizer is 2.0-3.0 microns, the fine particle fraction is not smaller than 60%, and the MK-7 content retention rate is not lower than 90% after 6 months of accelerated storage at 25-40 DEG C.

The utility model discloses a vitamin K2 mixing device which comprises a mixing device body, a cover plate is arranged at the top of the mixing device body, a supporting pipe is fixedly installed at the bottom of the mixing device body, and a mixing assembly is arranged in the supporting pipe. A transmission motor is started, the transmission motor drives a rotating rod to rotate, the rotating rod drives a dispersing plate to mix vitamins, meanwhile, a fan is started, the fan blows air into a fixed box, air enters the fixed box, and then dust in the air is filtered through a purifying plate and a filtering plate; and then clean air is conveyed into an air injection ring and is sprayed out through a spray head, so that vitamins can be blown up and fully and uniformly mixed, the uniform mixing device body achieves an efficient mixing effect, and an existing mode of mixing by using a single mixing rod is replaced, so that the efficient mixing effect is achieved, and the use of a user is facilitated.

The invention provides a micro-fat calcium supplement carrier, which is prepared from the following raw materials in parts by weight: 30 to 35 parts of standard index calcium, 1 to 5 parts of chondroitin, 1 to 5 parts of glucosamine, 8 to 12 parts of pure camel milk, 0.7 part of vitamin D, 2 to 70.3 parts of vitamin K, 1 to 3 parts of phospholipid complex and 8 to 10 parts of excipient. According to the invention, standard calcium, chondroitin, glucosamine, pure camel milk, vitamin D, vitamin K2-7, a phospholipid complex and an excipient are organically mixed by adopting a liposome carrier technology, so that the digestion and absorption of calcium in a body and the distribution of calcium in a specific region are effectively improved, and further the effects of rapid bone growth, increase of bone length (promotion of height increase) and increase of bone density are achieved; the health-care food has the health-care functions of reducing the fracture probability, preventing tooth decay, reducing the death rate of cardiovascular diseases and the like, so that the calcium absorption rate is remarkably improved and reaches up to 95%.

The invention discloses a pharmaceutical composition for treating or preventing postpartum depression of pregnant and lactating women, which is characterized by comprising a vitamin K2 compound or a pharmaceutically acceptable salt thereof and an optional pharmaceutically acceptable carrier, diluent or excipient. In particular, the pharmaceutical composition can also promote the development of the offspring brain and / or improve the learning ability.

The present disclosure relates to an improved method for regiospecific and stereospecific synthesis of polyisopentenyl compounds. More particularly, it discloses regiospecific and stereospecific synthesis of (2E, 6E, 10E, 14E, 18E, 22E)-3, 7, 11, 15, 19, 23, 27-heptamethyl octacosa-2, 6, 10, 14, 18, 22, 26 heptaen-1-ol useful for the synthesis of vitamin K2-7.

The application provides a vitamin premix and a preparation process thereof, and belongs to the technical field of food additives, and the preparation process is as follows: adding mixed microparticles of fat-soluble vitamins, mixed water-soluble vitamins and mixed minerals into a mixer and mixing, then adding vitamin C, magnesium taurate, amino acids and tricalcium phosphate and continuing to mix, and sieving to obtain the vitamin premix. The raw materials of the mixed microparticles of fat-soluble vitamins include vitamin A, vitamin E acetate, vitamin D3, vitamin K2, acacia, modified protein and beta-cyclodextrin; the raw materials of the mixed water-soluble vitamins include vitamin B1, vitamin B2, vitamin B5, vitamin B12, folic acid and nicotinamide; and the raw materials of the mixed minerals include ferrous glycinate, calcium citrate, magnesium citrate and zinc glycinate. The vitamin premix prepared by the application can be used in various foods as a nutritional supplement, is convenient to use, and has good stability and mixing uniformity.

The invention provides application of bacillus natto in fermentation of agrocybe cylindracea and co-production of polypeptide and vitamin K2 and a method, and belongs to the technical field of microbial fermention.The bacillus natto is used for fermentation of agrocybe cylindracea to obtain polypeptide and vitamin K2; the bacillus natto is preserved in Guangdong Microbial Culture Collection Center on October 21, 2020, and the preservation number of the bacillus natto is GDMCC No: 61234. The agrocybe cylindracea polypeptide and the vitamin K2 can be co-produced, compared with a traditional enzyme method for preparing the agrocybe cylindracea peptide, the method has the advantages of being high in conversion rate, simple in process, green, economical and the like, the fermented agrocybe cylindracea peptide has multiple functions of lowering cholesterol and blood sugar and resisting oxidation, and the method has very high application value and economic value.

The invention relates to the technical field of nutritional supplements, in particular to high-absorption compound calcium which comprises the following components: calcium, ferrous glycinate, zinc glycinate, magnesium, vitamin D3, vitamin K2, casein phosphopeptides and linolenic acid type grease. The invention relates to a calcium supplement, which comprises, by weight, 28%-39% of calcium, 0.5%-0.9% of ferrous glycinate, 0.6%-0.7% of zinc glycinate, 6%-9% of magnesium, 0.9%-1.1% of vitamin D3, 0.6%-0.9% of vitamin K2, 0.8%-1.3% of casein phosphopeptides, and 25%-41% of linolenic acid grease, and has the following beneficial effects: through a tricalcium-in-one technology, the total absorption rate of calcium is greatly improved. The common side effects of flatulence, constipation, black stool and the like of the traditional calcium supplement are avoided.

The invention provides bacillus subtilis and application thereof in fermentation production of vitamin K2, the bacillus subtilis is preserved in China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC No.35348, and the preservation date is July 28, 2025; according to the application of the bacillus subtilis in fermentation production of the vitamin K2, the unit yield of the vitamin K2 can be increased, and particularly, the vitamin K2 is the vitamin K2 (MK-7). When the bacillus subtilis is applied to fermentation production of the vitamin K2, the yield of the vitamin K2 (MK-7) can be increased, the average yield reaches up to 400 mg / L or above, the operation procedure is simple, the method is stable, reproducibility is good, and industrial production can be achieved easily.